Related Experiment Video

Updated: Jun 29, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Inhibition of human metapneumovirus replication by small interfering RNA

Céline Deffrasnes1, Marie-Hélène Cavanagh, Nathalie Goyette

  • 1Infectious Disease Research Centre of the Centre Hospitalier Universitaire de Québec, Laval University, Quebec City, QC, Canada.

Antiviral Therapy
|October 9, 2008
PubMed
Abstract

Insights

Researchers identified two potent small interfering RNAs (siRNAs) to combat human metapneumovirus (hMPV) by targeting its replication complex. This RNA interference strategy shows promise for developing new hMPV treatments.

Area of Science:

  • Virology
  • Molecular Biology
  • RNA Interference Therapeutics

Background:

  • Human metapneumovirus (hMPV) is a significant respiratory pathogen causing severe illness in vulnerable populations.
  • Current treatments and vaccines for hMPV are lacking, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To develop an effective RNA interference (RNAi) therapeutic strategy against human metapneumovirus (hMPV).

Main Methods:

  • Computational screening identified 200 potential 21-mer small interfering RNAs (siRNAs) targeting the hMPV genome.
  • Luciferase assays and quantitative PCR validated siRNA efficacy, identifying two highly potent candidates.
  • Dicer substrates were evaluated, demonstrating comparable or superior efficacy to 21-mer siRNAs.

Main Results:

  • Two highly potent siRNAs (siRNA45 and siRNA60) were identified, targeting nucleoprotein and phosphoprotein mRNAs, respectively.
  • These siRNAs exhibited subnanomolar IC50 values against all four hMPV subgroups in vitro.
  • In vitro inhibition was observed even with minor nucleotide mismatches in target sequences.

Conclusions:

  • Two highly efficient siRNAs targeting essential hMPV replication complex components were successfully identified.
  • This study provides a strong foundation for developing RNAi-based therapies against hMPV infections.

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...